Cervomed Stock Alpha and Beta Analysis
| CRVO Stock | 8.48 0.06 0.71% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as CervoMed. It also helps investors analyze the systematic and unsystematic risks associated with investing in CervoMed over a specified time horizon. Remember, high CervoMed's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to CervoMed's market risk premium analysis include:
Beta 0.67 | Alpha 0.064 | Risk 3.92 | Sharpe Ratio 0.0289 | Expected Return 0.11 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out CervoMed Backtesting, CervoMed Valuation, CervoMed Correlation, CervoMed Hype Analysis, CervoMed Volatility, CervoMed History and analyze CervoMed Performance. CervoMed Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. CervoMed market risk premium is the additional return an investor will receive from holding CervoMed long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in CervoMed. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate CervoMed's performance over market.| α | 0.06 | β | 0.67 |
CervoMed expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of CervoMed's Buy-and-hold return. Our buy-and-hold chart shows how CervoMed performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.CervoMed Market Price Analysis
Market price analysis indicators help investors to evaluate how CervoMed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CervoMed shares will generate the highest return on investment. By understating and applying CervoMed stock market price indicators, traders can identify CervoMed position entry and exit signals to maximize returns.
CervoMed Return and Market Media
The median price of CervoMed for the period between Fri, Sep 26, 2025 and Thu, Dec 25, 2025 is 8.15 with a coefficient of variation of 9.68. The daily time series for the period is distributed with a sample standard deviation of 0.78, arithmetic mean of 8.05, and mean deviation of 0.63. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | CervoMed Drug Cut Dementia Progression Risk By 75 percent In Trial | 10/08/2025 |
2 | CervoMed Appoints David Quigley to Board of Directors - TipRanks | 10/29/2025 |
3 | Acquisition by Alam John J of 5553 shares of CervoMed at 7.35 subject to Rule 16b-3 | 11/12/2025 |
4 | Thompson Davis CO. Inc. Takes 88,000 Position in CervoMed Inc. CRVO | 11/14/2025 |
5 | Acquisition by Alam John J of 10793 shares of CervoMed at 8.46 subject to Rule 16b-3 | 11/17/2025 |
6 | CervoMed CEO John Alam Purchases 10,807 Shares | 11/19/2025 |
7 | CervoMed CFO William Robert Elder Acquires 2,500 Shares of Stock | 11/20/2025 |
8 | CervoMed to Share New Data on Neflamapimod as a Treatment for Dementia with Lewy Bodies at the 18th Clinical Trials on Alzheimers Disease Conference | 11/24/2025 |
9 | CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies | 12/02/2025 |
10 | CervoMeds Promising Phase 2b Trial Results for DLB - TipRanks | 12/05/2025 |
11 | Will CervoMed Inc. stock gain from strong economy - Weekly Trend Recap Daily Volume Surge Signals - Blm Sonu Canavar | 12/19/2025 |
About CervoMed Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including CervoMed or other stocks. Alpha measures the amount that position in CervoMed has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 (projected) | Interest Debt Per Share | 27.55 | 26.18 | Revenue Per Share | 1.21 | 1.15 |
CervoMed Upcoming Company Events
As portrayed in its financial statements, the presentation of CervoMed's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CervoMed's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of CervoMed's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of CervoMed. Please utilize our Beneish M Score to check the likelihood of CervoMed's management manipulating its earnings.
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with CervoMed
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out CervoMed Backtesting, CervoMed Valuation, CervoMed Correlation, CervoMed Hype Analysis, CervoMed Volatility, CervoMed History and analyze CervoMed Performance. To learn how to invest in CervoMed Stock, please use our How to Invest in CervoMed guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
CervoMed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.